Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) †
Titel:
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) †
Auteur:
Koeberle, D. Dufour, J.-F. Demeter, G. Li, Q. Ribi, K. Samaras, P. Saletti, P. Roth, A.D. Horber, D. Buehlmann, M. Wagner, A.D. Montemurro, M. Lakatos, G. Feilchenfeldt, J. Peck-Radosavljevic, M. Rauch, D. Tschanz, B. Bodoky, G.